KALA BIO, Inc. (KALA) News
Follow KALA BIO, Inc. (KALA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of FingerMotion Inc (NASDAQ: FNGR ) rose sharply in pre-market trading after the company announced it had entered into a definitive Share Purchase Agreement to acquire 100% of Newbit Technology Inc. Under the agre
LIVE | Sep 30, 2026, 09:32 AM UTC
L
KALA BIO, Inc. (KALA) Signs LOI to Buy Telehealth MSO for ~$15M
KALA BIO, Inc. signed a non-binding LOI to acquire a 50-state telehealth MSO for approximately $15M, funded with cash and stock. The Target reported unaudited TTM revenue of ~$12.7M and ~$48M sales since 2023; closing is
MNA | Sep 29, 2026, 11:32 AM UTC
L
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Proposed Acquisition Valued at Approximately $15 Million Would Add an Established 50-State Telehealth Business, with over 90,000 clients, Focused on Peptides such as GLP-1 Weight Management, Hormone Health, Longevity and
MNA | Sep 29, 2026, 11:31 AM UTC
L
Kala Bio, Inc. (KALA) Signs LOI for Added U.S. Genomics Reseller Channel
Kala Bio and Virotek signed a non-binding LOI with a U.S. DNA testing platform to resell selected Virotek genomic tests. Terms are being finalized; definitive agreements, parties and revenue are not assured.Material Deta
NEWS | Sep 24, 2026, 11:33 AM UTC
L
KALA - Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
KALA - Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
NEWS | Sep 24, 2026, 11:30 AM UTC
L
KALA - KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
KALA - KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
NEWS | Sep 17, 2026, 11:30 AM UTC
M
Kala Bio and Virotek finalize exclusive U.S. distribution deal
Kala Bio and Virotek finalized a definitive agreement for an exclusive U.S. distribution partnership for an ophthalmology genetic testing program.
EQUITY | Sep 03, 2026, 12:31 PM UTC
L
Kala Bio and Virotek sign LOI for exclusive U.S. ophthalmology testing distribution
Kala Bio and Virotek announced a letter of intent for an exclusive U.S. distribution partnership for an ophthalmology genetic testing program.
EQUITY | Sep 01, 2026, 11:45 AM UTC
L
KALA BIO disclosed failure to satisfy continued listing rule
KALA BIO disclosed failure to satisfy a continued listing rule or standard.
EQUITY | Aug 28, 2026, 10:54 AM UTC